29
Oversold
Moving averages
SMA 200$1.04-44.02%
Company profile
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$64.41M
P/E ratioNone
EPS$-0.16
Beta1.799
Dividend yield0.00%
52-week high$1.81
52-week low$0.55
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
HRTX
Heron Therapeutics Inc
RSI 39
IBIO
iBio Inc
RSI 52
CHRS
Coherus Biosciences Inc
RSI 24
CRBU
Caribou Biosciences Inc
RSI 22
IMUX
Immunic Inc
RSI 45
SAVA
Cassava Sciences Inc
RSI alerts for CGTX
An email when CGTX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:43 AM EST